AKT Health has announced 'HAIOps', a specialized framework for medical AI operations. Unlike standard MLOps, HAIOps focuses on regulatory traceability, safety monitoring, and clinical bias analysis tailored for life sciences. The framework addresses high failure rates in AI deployment by ensuring transparency and auditability in line with FDA 21 CFR Part 11 and EU AI Act regulations. This strategy empowers pharmaceutical companies to operationalize AI responsibly within complex regulatory ecosystems.